Page last updated: 2024-12-05

indene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indene is a bicyclic aromatic hydrocarbon with a five-membered ring fused to a six-membered ring, containing a double bond. It is a colorless liquid that is soluble in organic solvents and has a strong, pungent odor. Indene is a building block for the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and polymers. It is also used in the production of resins and dyes. Indene is a reactive molecule and can undergo a variety of chemical reactions, including electrophilic aromatic substitution, Diels-Alder reactions, and polymerization. The compound is a subject of research due to its potential applications in the development of new materials, catalysts, and pharmaceuticals. For instance, indene derivatives are known to exhibit anticancer, antimicrobial, and anti-inflammatory activities. Research on indene derivatives is also focused on understanding their mechanisms of action and developing more effective and targeted therapies.'

indene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1H-indene : An ortho-fused bicyclic arene comprising of benzene and cyclopentene rings. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7219
CHEMBL ID192812
CHEBI ID41921
MeSH IDM0246761

Synonyms (54)

Synonym
EN300-19944
nsc 9270
hsdb 5286
einecs 202-393-6
nsc-62567
nsc62567
9003-64-9
indene
nsc-9270
nsc9270
95-13-6
inden
wln: l56 bhj
indonaphthene
1h-indene
inchi=1/c9h8/c1-2-5-9-7-3-6-8(9)4-1/h1-6h,7h
indene, contains 50-100 ppm tert-butylcatechol as stabilizer, technical grade, >=90%
CHEBI:41921 ,
indene, >=99%
indene, 98%
I-0750
AKOS000269048
bdbm50167941
CHEMBL192812 ,
I0354
I0016
A845191
71551-80-9
indenyl radical
dtxsid8042052 ,
cas-95-13-6
dtxcid6022052
NCGC00255989-01
tox21_301215
67h8y6lb8a ,
unii-67h8y6lb8a
FT-0627195
AM20060846
indene [hsdb]
indene [mi]
STL268869
AKOS025243274
F0001-2266
mfcd00003777
indene, analytical standard
indene 10 microg/ml in methanol
CS-0015092
Q421008
indene, (1h-indene)
Q27115417
D72500
BS-22312
CS-0198083
Z104476162

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This study using Rhodococcus I24 reports on the application of multiparameter flow cytometry for the measurement of cell physiological properties based on cytoplasmic membrane (CM) integrity and membrane depolarization as indicators of toxic effects of the substrate, indene."( Application of multi-parameter flow cytometry using fluorescent probes to study substrate toxicity in the indene bioconversion.
Amanullah, A; Buckland, BC; Chartrain, M; Drew, SW; Hewitt, CJ; Lee, C; Nienow, AW; Woodley, JM, 2002
)
0.71
" This study reports on the application of multiparameter flow cytometry for the measurement of cytoplasmic membrane integrity and membrane depolarization as indicators of toxic effects of the substrate, product, and by-products using each of these strains."( Measurement of strain-dependent toxicity in the indene bioconversion using multiparameter flow cytometry.
Amanullah, A; Buckland, BC; Chartrain, M; Drew, SW; Hewitt, CJ; Lee, C; Nienow, AW; Woodley, JM, 2003
)
0.57

Pharmacokinetics

ExcerptReferenceRelevance
" One of these compounds, 10a, showed equivalent efficacy in a rat EEG/EMG model to a previously identified clinical candidate and a potentially superior pharmacokinetic profile as determined from a human microdose study."( Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.
Beaton, G; Bradbury, MJ; Coon, T; Crowe, PD; Hernandez, LM; Hoare, SR; Huang, C; Jalali, K; Li, BF; Madan, A; Malany, S; Marinkovic, D; Moree, WJ; Petroski, RE; Sacaan, A; Tucci, FC; Wang, H; Wen, J; Yang, C; Yu, J; Zamani-Kord, S, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
indene
ortho-fused bicyclic arene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency49.99650.001022.650876.6163AID1224838; AID1224839; AID1224893
estrogen nuclear receptor alphaHomo sapiens (human)Potency76.95880.000229.305416,493.5996AID743079
aryl hydrocarbon receptorHomo sapiens (human)Potency20.49570.000723.06741,258.9301AID743085; AID743122
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
EndolysinTequatrovirus T4Kd193.00003.00003.00003.0000AID238119
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID281484Inhibition of rabbit liver carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID1149945Inhibition of chymotrypsin (unknown origin)1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID281483Inhibition of human liver CE1 expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID281482Inhibition of human intestinal carboxylesterase expressed in sf21 cells up to 100 uM2007Journal of medicinal chemistry, Apr-19, Volume: 50, Issue:8
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
AID238119Dissociation constant against T4 lysozyme mutant L99A2005Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
Decoys for docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (9.30)18.7374
1990's6 (6.98)18.2507
2000's33 (38.37)29.6817
2010's28 (32.56)24.3611
2020's11 (12.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.00 (24.57)
Research Supply Index4.47 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index91.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.16%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other85 (98.84%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]